The study used a single high dose and did not evaluate symptoms, disease outcomes or long-term use
Nie Z-J, Zhang Y-G, Chang Y-H, Li Q-Y, Zhang Y-L
Calibrate: $300$500+/month, bundling medication, coaching, and assessments
Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers
Because an oral 15-PGDH inhibitor has already passed Phase 1 safety testing in humans for age-related #muscle weakness, the authors are hopeful that clinical trials in joint disease will follow, potentially paving the way for #nonsurgical, cartilage-regenerating therapies that could delay or replace knee and hip replacements
Consider alternative treatments Besides semaglutide and other GLP-1s that are still being studied for fatty liver disease, there are other well-studied and FDA-approved treatment options for NAFLD